Lin Feng

8.3k total citations
184 papers, 5.5k citations indexed

About

Lin Feng is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Lin Feng has authored 184 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 115 papers in Molecular Biology, 46 papers in Cancer Research and 36 papers in Oncology. Recurrent topics in Lin Feng's work include Cancer-related molecular mechanisms research (19 papers), MicroRNA in disease regulation (15 papers) and RNA modifications and cancer (14 papers). Lin Feng is often cited by papers focused on Cancer-related molecular mechanisms research (19 papers), MicroRNA in disease regulation (15 papers) and RNA modifications and cancer (14 papers). Lin Feng collaborates with scholars based in China, United States and United Kingdom. Lin Feng's co-authors include Junjie Chen, Wenqi Wang, Jiadong Wang, Junchao Duan, Zhiwei Sun, Xiaozhe Yang, Dong‐bao Chen, Jun Huang, Hejing Hu and Xu Li and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Lin Feng

180 papers receiving 5.5k citations

Peers

Countries citing papers authored by Lin Feng

Since Specialization

Citations

This map shows the geographic impact of Lin Feng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin Feng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin Feng more than expected).

Fields of papers citing papers by Lin Feng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lin Feng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin Feng. The network helps show where Lin Feng may publish in the future.

Co-authorship network of co-authors of Lin Feng

This figure shows the co-authorship network connecting the top 25 collaborators of Lin Feng. A scholar is included among the top collaborators of Lin Feng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lin Feng. Lin Feng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The metabolic enzyme GYS1 condenses with NONO/p54nrb in the nucleus and spatiotemporally regulates glycogenesis and myogenic differentiation 2025 ·Cell Death and Differentiation ·Shouyong Peng, (unknown), Yifan Wang, (unknown), Xinyu Chen, Yujing Yin, Fan Yang, Feng-Zhi Chen, (unknown), (unknown), Baicheng Chen, Haowen Shi, Qingrun Li, Yu Zhao, Lin Feng, Zhenji Gan, Xiaoduo Xie	1
2	ROS responsive nanozyme loaded with STING silencing for the treatment of sepsis-induced acute lung injury 2024 ·Toxicology and Applied Pharmacology ·(unknown), (unknown), Lin Feng, Xia Zhang, (unknown), (unknown)	3
3	NOP14-mediated ribosome biogenesis is required for mTORC2 activation and predicts rapamycin sensitivity 2024 ·Journal of Biological Chemistry ·Yan Xiao, (unknown), (unknown), Ruihua Wang, Jinzhong Lin, Yi‐Xin Zeng, Xiaoduo Xie, Lin Feng	2
4	Association of 4qA-Specific Distal D4Z4 Hypomethylation With Disease Severity and Progression in Facioscapulohumeral Muscular Dystrophy 2023 ·Neurology ·(unknown), (unknown), Long Chen, Ying Zheng, Xiaodan Lin, (unknown), (unknown), (unknown), (unknown), Lin Lin, Lili Wang, Lin Feng, (unknown), Min-Ting Lin, Yi Lin, Ying Fu, Ning Wang, Zhi‐Qiang Wang	9
5	HLA-Bw4 in association with KIR3DL1 favors natural killer cell-mediated protection against severe COVID-19 2023 ·Emerging Microbes & Infections ·Ruihua Wang, Ying Sun, (unknown), (unknown), (unknown), (unknown), (unknown), Yating Li, Xiaoduo Xie, Tao Chen, Hui Zhang, Yi‐Xin Zeng, Jincun Zhao, Lin Feng	5
6	CRL2KLHDC3 mediates p14ARF N-terminal ubiquitylation degradation to promote non-small cell lung carcinoma progression 2022 ·Oncogene ·Yang Liu, Yuewen Luo, Shumei Yan, Yifan Lian, Shiyu Wu, Miao Xu, Lin Feng, Xu Zhang, Rong Li, Xiantao Zhang, Qi‐Sheng Feng, Yi‐Xin Zeng, Hui Zhang	10
7	Genome profiles of pathologist-defined cell clusters by multiregional LCM and G&T-seq in one triple-negative breast cancer patient 2021 ·Cell Reports Medicine ·Zhongyi Zhu, Weiwei Wang, Lin Feng, (unknown), Guibo Li, (unknown), (unknown), Anil A. Joy, Chao Chen, (unknown), Xi Zhang, Qing Zhou, Lynne‐Marie Postovit, Xiuqing Zhang, Yong Hou, John R. Mackey, Bo Li, Gane Ka‐Shu Wong	6
8	Structure of Epstein-Barr virus tegument protein complex BBRF2-BSRF1 reveals its potential role in viral envelopment 2020 ·Nature Communications ·(unknown), (unknown), Yu-Lu Cao, Yuxin Lin, Hua Zhang, Xiao Zhang, (unknown), Bing Yu, Xiaoxue Chen, Miao Xu, Lin Feng, Mu‐Sheng Zeng, Yi‐Xin Zeng, Song Gao	15
9	SHROOM2 inhibits tumor metastasis through RhoA–ROCK pathway-dependent and -independent mechanisms in nasopharyngeal carcinoma 2019 ·Cell Death and Disease ·Jing Yuan, Lin Chen, (unknown), (unknown), Ji Zhang, Xu Li, Zifeng Wang, (unknown), Tong Xiang, Yuchen Zhang, Ming‐Yuan Chen, Jin‐Xin Bei, Yi‐Xin Zeng, Lin Feng	29
10	TNFRSF19 Inhibits TGFβ Signaling through Interaction with TGFβ Receptor Type I to Promote Tumorigenesis 2018 ·Cancer Research ·Cheng‐Cheng Deng, (unknown), (unknown), (unknown), Yuchen Zhang, Hao-Jiong Zhang, Miao Xu, Qi-Sheng Feng, Jin‐Xin Bei, Yi-Xin Zeng, Lin Feng	34
11	Induction of chemokine (C‐C motif) ligand 5 by Epstein–Barr virus infection enhances tumor angiogenesis in nasopharyngeal carcinoma 2018 ·Cancer Science ·(unknown), Lin Feng, Shanshan Zhang, (unknown), Xiao Zhang, (unknown), Yuchen Zhang, Qi‐Sheng Feng, Tong Xiang, Yi‐Xin Zeng	29
12	The photocatalytic reaction of imperatorin and cysteine 2018 ·Main Group Chemistry ·(unknown), Lin Feng, (unknown), (unknown), Hailong Zhang, (unknown), (unknown), Zhiming Zhou, Xiaohua Zhou, (unknown), (unknown)	0
13	Micellar Delivery of miR-34a Modulator Rubone and Paclitaxel in Resistant Prostate Cancer 2017 ·Cancer Research ·Di Wen, Yang Peng, Lin Feng, Rakesh K. Singh, Ram I. Mahato	60
14	CLONING AND PROKARYOTIC EXPRESSION OF GALECTIN FROM PORTUNUS TRITUBERCULATUS 2016 ·Guijie Hao, Lin Feng, (unknown), Ronghua Li, Jiayun Yao, Xiaoyi Pan, Xuemei Yuan, Jinyu Shen, (unknown)	1
15	MiR-374a promotes the proliferation of human osteosarcoma by downregulating FOXO1 expression. 2015 ·Europe PMC (PubMed Central) ·Wenbo He, Lin Feng, (unknown), (unknown)	23
16	Decreased Interferon Alpha/Beta Signature Associated with Human Lung Tumorigenesis 2015 ·Journal of Interferon & Cytokine Research ·(unknown), Lin Feng, Lei Zhang, Jianzhi Zhang, Yousheng Mao, Kaitai Zhang, Yanning Gao, Guiqi Wang, Shujun Cheng	9
17	Preeclampsia Up-Regulates Angiogenesis-Associated MicroRNA ( i.e ., miR-17, -20a, and -20b) That Target Ephrin-B2 and EPHB4 in Human Placenta 2012 ·The Journal of Clinical Endocrinology & Metabolism ·Wen Wang, Lin Feng, Honghai Zhang, (unknown), Seiro Satohisa, Louise C. Laurent, Mana M. Parast, Jing Zheng, Dong‐bao Chen	153
18	[Association of HER2 protein expression with clinicopathologic features and prognosis in Chinese patients with gastric carcinoma]. 2011 ·PubMed ·Hongmei Wu, Yan‐Hui Liu, Lin Feng, Fangping Xu, Donglan Luo, Fen Zhang, (unknown), Xin-lan Luo, (unknown), (unknown)	10
19	Spatial regulation of Raf kinase signaling by RKTG 2007 ·Proceedings of the National Academy of Sciences ·Lin Feng, Xiaoduo Xie, Qiurong Ding, Xiaolin Luo, Jing He, Fengjuan Fan, Weizhong Liu, Zhenzhen Wang, Yan Chen	102
20	Affecting factors of prognosis for total mesorectal excision of the rectal cancer 2005 ·Lin Feng	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact